:

VARDA EXPANDS SPACE DRUG MANUFACTURING AFTER HIV SUCCESS

AI DESK1 MIN READ
WED, MAY 13, 2026

■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE

Varda Space Industries is scaling up its orbital pharmaceutical operations following successful crystallization of HIV medication Ritonavir in space. CEO Will Bruey announced plans to broaden the company's drug manufacturing beyond this initial achievement.

Varda's recent win with Ritonavir marks a validation of its core business model: manufacturing pharmaceuticals in microgravity environments where different crystalline structures can form compared to Earth-based production. The unique properties of space-grown crystals could improve drug efficacy or bioavailability for certain medications. The company plans to leverage this proof-of-concept to develop additional drugs for orbital production. Varda operates in-space manufacturing spacecraft designed to return crystallized compounds to Earth for further development and commercialization. This expansion reflects growing investor interest in space-based manufacturing. Companies increasingly view microgravity as a viable production environment for high-value pharmaceuticals where Earth-based constraints limit results. Varda joins a small cohort of firms exploring orbital manufacturing, though most remain in early-stage development. The company's successful Ritonavir crystallization demonstration positions it as a near-term leader in commercializing this emerging sector.

■ SOURCES

Bloomberg Tech

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

Livestream shopping platform Whatnot has acquired AI startup Shaped to enhance its recommendation engine. The deal strengthens Whatnot's personalization capabilities as it expands into new product categories.

JUST NOWIndustry Desk

Amsterdam-based Monumental secured a $32 million Series B round led by Khosla Ventures. The company develops autonomous robotics and AI software for the construction industry.

1H AGOAI Desk

Indian AI coding startup Emergent reached a $1.5 billion valuation in its latest funding round, raising $130 million in Series C and joining the unicorn club after a five-fold valuation jump in six months.

4H AGOAI Desk

Rime, an AI platform processing over 100 million calls monthly, secured $24 million in Series A funding to expand its customer service solutions for enterprises.

4H AGOIndustry Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.